Neuropsychopharmacology
- Closed-loop neurostimulation for the treatment of psychiatric disorders3 years ago
- Calcitonin receptor signaling in nucleus accumbens D1R- and D2R-expressing medium spiny neurons bidirectionally alters opioid taking in male rats3 years ago
- Correction: Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trial3 years ago
- Advancing preclinical chronic stress models to promote therapeutic discovery for human stress disorders3 years ago
- PET imaging of dopamine transporters and D2/D3 receptors in female monkeys: effects of chronic cocaine self-administration3 years ago
- Deficits in integrative NMDA receptors caused by Grin1 disruption can be rescued in adulthood3 years ago
- No time to lose: the current state of research in rapid-acting psychotherapeutics3 years ago
Journal of Psychopharmacology
- Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trial7 years ago
- Corrigendum to The Australian Drug Harms Ranking Study7 years ago
- Benzodiazepines, antidepressants and addiction: A plea for conceptual rigor and consistency7 years ago
- Effects of selective serotonin reuptake inhibitors on DNA damage in patients with depression7 years ago
- Social cognition impairments in long-term opiate users in treatment7 years ago
- Sex influences in the preventive effects of N-acetylcysteine in a two-hit animal model of schizophrenia7 years ago
- Acute stress in adolescence vs early adulthood following selective deletion of dysbindin-1A: Effects on anxiety, cognition and other schizophrenia-related phenotypes7 years ago
European Neuropsychopharmacology
- P.820Pharmacological inhibition of soluble epoxide hydrolase protects cognitive impairment in a Niemann-Pick mice model6 years ago
- P.850Real-world effectiveness of aripiprazole long-acting injectable6 years ago
- P.824Positive and negative symptoms, cognitive deficits and antipsychotic treatment in schizophrenic patients6 years ago
- P.851Differences in healthcare resource utilization across oral atypical antipsychotic treatments in patients with schizophrenia6 years ago
- P.829Clinical characteristics of schizophrenia offspring, children diagnosed with attention deficit hiperactivity disorder and healthy controls6 years ago
- P.855Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: pooled analysis of double-blind, placebo-controlled 6-week studies6 years ago
- P.830A systematic review of antidepressant use in patients with delusional disorder: when and how?6 years ago